Procter & Gamble Health Ltd Share Price Today - Procter & Gamble Health Ltd Stock Price Live NSE/BSE

Procter & Gamble Health Ltd

NSE: PGHL BSE: 500126

₹5305

(0.04)%

Sun, 01 Feb 2026, 10:17 pm

MTF 5xInvest in Procter & Gamble Health Ltd with 5x Leverage Buy with MTF

Market Cap87.98B

PE Ratio28.70

Dividend2.36

Health Technology

Pharmaceuticals: Major

24.5K

1 Day

0 (0%)

No Result Found

Summary

Market Cap
8797.84
Net Profit
234.41
P/B
15.90
Sector P/E
39.08
P/E
48.55
EV/EBITDA
25.42
Debt/Equity (Industry)
0.08
Interest Cover (Industry)
146.92
ROCE (Industry)
20.66
RONW (Industry)
16.60
ROE
32.74
ROCE
40.23
Debt/Equity
0.01
EPS (TTM)
184.83
Dividend Yield
2.36
Book Value
373.34
Interest Cover
725.70

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (4.1x coverage).
Procter & Gamble Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Procter & Gamble Health is profitable, therefore cash runway is not a concern.
Procter & Gamble Health is profitable, therefore cash runway is not a concern.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Procter & Gamble Health's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Procter & Gamble Health's dividend is below the markets top 25% of dividend payers in India (3.08%).
High level of physical assets or inventory.
The average tenure for the Procter & Gamble Health board of directors is less than 3 years, this suggests a new board.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	51.82	51.82	51.82	51.82	51.82
FII	6.97	7.24	6.99	6.87	7.01
DII	13.84	13.91	14.16	14.21	14.71
Public	27.37	27.04	27.03	27.11	26.46
Government	0	0	0	0	0

Technical Analysis

RSI

28.51

MACD

-96.82

50 DMA

5628.40

200 DMA

5829.63

Support and Resistance

Type	R1	R2	R3	PP	S1	S2	S3
Classic	6745.67	6123.67	5713.33	5501.67	5091.33	4879.67	4257.67
Fibonacci	6123.67	5886.06	5739.27	5501.67	5264.06	5117.27	4879.67
Camarilla	5474.05	5417.03	5360.02	5501.67	5245.98	5188.97	5131.95

Pivots Level: Classic

+1244

6745.67

+622

6123.67

+211.67

5713.33

5501.67

Pivot Point

LTP: 5305

-410.33

5091.33

-622

4879.67

-1244

4257.67

Moving Average

SMAEMA

Period

Value

10-EMA
5382.96
20-EMA
5458.22
30-EMA
5519.73
50-EMA
5620.99
100-EMA
5752.90
200-EMA
5748.18

Announcement Date	Purpose	Action	Ex Date
05 Nov 2025	board-meetings	Quarterly Results, Interim Dividend
06 Aug 2025	agm
29 May 2025	dividend	₹45.00 Dividend /Share	22 Aug 2025
12 Feb 2025	dividend	₹80.00 Dividend /Share	21 Feb 2025
22 Aug 2024	agm
21 Aug 2024	dividend	₹60.00 Dividend /Share	29 Nov 2024
06 Feb 2024	dividend	₹50.00 Dividend /Share	14 Feb 2024
24 Aug 2023	agm
23 Aug 2023	dividend	₹50.00 Dividend /Share	24 Nov 2023
05 Feb 2023	dividend	₹45.00 Dividend /Share	13 Feb 2023

Procter & Gamble Health Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Cipla Ltd

Divis Laboratories Ltd

About Procter & Gamble Health Ltd

Procter & Gamble Health is in the business of manufacturing and marketing of pharmaceuticals.

Industry

Pharmaceuticals - Multinational

Founded

1967

Headquarters

CEO

S Madhavan

Employees

Contact

Website

http://www.pghealthindia.com

investorgrievance.im@pg.com

Phone

91-22-62109000

Location

Godrej One 8th Floor, Projshanagar Vikhroli (East), Mumbai, Maharashtra, 400079

Year	History
2020	P&G Health partnered with PHFI for Digital Health Project at Goa under SEHAT CSR Program.
2021	P&G Health partnered with Tata Trusts to advance nutritional status of women and children in Andhra Pradesh. P&G Health commemorated Iron Deficiency Day with GUINNESS WORLD RECORDS achievement.
2022	P&G Health launched Na Na Anemia Bus Yatra across 20 cities for Iron Deficiency Anemia awareness. P&G Health partnered with Lakshya and Recycle India Foundation for sustainable pharmacy waste management. P&G Health brought global nerve care experts together for Peripheral Neuropathy awareness. P&G Health partnered with Apnalaya to improve maternal and newborn health in Mumbai slums.
2023	P&G Health partnered with Indian Academy of Pediatrics for Sankalp: Sampoorna Swasthya school healthcare initiative. P&G Health launched Mobile Healthcare Unit with HelpAge India in Guwahati. P&G Health collaborated with Indian Medical Association to launch VitaM.I.N.D.S conclave. Polybion celebrated World Health Day and launched Pragati Utsav for Vitamin B Deficiency awareness.
2024	P&G Health and HelpAge India collaborated to improve healthcare access in Palghar. P&G Health's Nasivion entered Asia Book of Records. P&G Health achieved GUINNESS WORLD RECORDS title for largest online photo album of people wearing pin badges.

Client Name	Order Side	QTY	Avg Price	Date
No Result Found

procter & gamble health limite News

P&G Health Board to Consider Interim Dividend on Feb 6

Procter & Gamble Health Limited has revised its board meeting agenda for February 6, 2026, to include consideration of interim dividend declaration for FY26, in addition to previously scheduled matters.

21 Jan 2026

co actions results

Procter & Gamble Health Limited Appoints Shashank Srowthy as Executive Director

Procter & Gamble Health Limited confirmed the appointment of Shashank Srowthy as Executive Director for five years effective October 1, 2025, following shareholder approval through postal ballot on November 16, 2025. Srowthy brings 14 years of finance experience across PG operations in India, Dubai and Singapore, and holds no shares in the company nor any relationship with existing directors.

18 Nov 2025

corporate action

Procter & Gamble Health Limited Reports Quarterly Financial Results

Procter & Gamble Health Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from operations of ₹54.5 crores for the quarter, compared to ₹54.7 crores in the previous quarter and ₹51.1 crores in the corresponding quarter of the previous year. Net profit for the quarter stood at ₹88.6 crores, significantly higher than ₹66.2 crores in the previous quarter and ₹82.5 crores in the same quarter last year. For the six-month period ended September 30, 2025, revenue was ₹109.3 crores with net profit of ₹154.8 crores. The company's earnings per share for the quarter was ₹53.34. Cash and cash equivalents increased to ₹279.3 crores as of September 30, 2025, from ₹182.3 crores as of March 31, 2025. The Board of Directors approved these results at a meeting held on November 5, 2025.

05 Nov 2025

earnings

Procter & Gamble Health Reports Higher Q2 Profit and Revenue Growth

Procter & Gamble Health reported Q2 net profit of 885.4 million rupees compared to 823.3 million rupees in the same period last year. Revenue increased to 3.25 billion rupees from 3.13 billion rupees year-over-year. EBITDA rose to 1.2 billion rupees from 1.14 billion rupees, while EBITDA margin improved to 37.02% from 36.39% in the previous year.

05 Nov 2025

earnings

Procter & Gamble Health Limited Completes Director Appointment Process for Shashank Srowthy

Procter & Gamble Health Limited announced that Mr. Shashank Srowthy has been allotted Director Identification Number (DIN) 11317956 by the Ministry of Corporate Affairs. Srowthy was appointed as Additional Director (Executive) effective October 1, 2025. The DIN was allotted through an order dated September 26, 2025, completing the appointment process that was initially announced on September 16, 2025.

01 Oct 2025

corporate governance

Showing 1–5 of 26

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800